NCT03089112

Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501

A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic Drug Interactions and the Safety Between HGP1607 and HGP1501 in Healthy Male Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Hanmi Pharmaceutical Company Limited · Industry
• Sex: Male
• Age: 19 Years – 40 Years
• Healthy volunteers: Accepted

Summary

A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic drug interactions and the Safety between HGP1607 and HGP1501 in Healthy Male Volunteers

Conditions

• Healthy Male Volunteers

Interventions

Type	Name	Description
DRUG	HGP1607	Take it once per period
DRUG	HGP1501	Take it once per period
DRUG	HGP1607+HGP1501	Take it once per period

Timeline

• Start date: 2017-03-31
• Primary completion: 2017-05-28
• Completion: 2017-06-16
• First posted: 2017-03-24
• Last updated: 2022-11-10

Locations

1 site across 1 country: South Korea